Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus

Journal of the American Academy of Nurse Practitioners

Volumn 20, Issue 2, 2008, Pages 85-92

  Farley, Jason E ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Community acquired; MRSA; Staphylococcus aureus

Indexed keywords

COMMUNICABLE DISEASE; CROSS INFECTION; EPIDEMIOLOGY; HUMAN; MICROBIOLOGICAL EXAMINATION; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PENICILLIN RESISTANCE; REVIEW; RISK FACTOR; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

COMMUNICABLE DISEASES, EMERGING; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EPIDEMIOLOGY, MOLECULAR; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING ASSESSMENT; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 38949148612     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2007.00290.x     Document Type: Review

References (72)

1. Adam, H., McGeer, A. Simor, A 2007). Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Canada Communicable Disease Report, 33, 45 48.
2. Adcock, P. M., Pastor, P., Medley, F., Patterson, J. E. Murphy, T. V. (1998). Methicillin-resistant Staphylococcus aureus in two child care centers. Journal of Infectious Diseases, 178, 577 580.
3. Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K., Oguchi, A., et al 2002). Genome and virulence determinants of high virulence community-acquired MRSA. Lancet, 359, 1819 1827.
4. Baggett, H. C., Hennessy, T. W., Leman, R., Hamlin, C., Bruden, D., Reasonover, A., et al 2003). An outbreak of community-onset methicillin- resistant Staphylococcus aureus skin infections in southwestern Alaska. Infection Control and Hospital Epidemiology, 24, 397 402.
5. Barber, M 1948). Infection by penicillin-resistant staphylococci. Rozwadowska-Dowzenko, M. Lancet, 1, 641 644.
6. Barrett, F. F., McGehee, R. F., Jr. Finland, M 1968). Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. New England Journal of Medicine, 279, 441 448.
7. Borer, A., Gilad, J., Yagupsky, P., Peled, N., Porat, N., Trefler, R., et al 2002). Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerging Infectious Diseases, 8, 966 970.
8. Bratu, S., Eramo, A., Kopec, R., Coughlin, E., Ghitan, M., Yost, R., et al 2005). Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerging Infectious Diseases, 11, 808 813.
9. Bratu, S., Landman, D., Gupta, J., Trehan, M., Panwar, M. Quale, J 2006). A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City. Annals of Clinical Microbiology and Antimicrobials, 5, 29.
10. Brumfitt, W. Hamilton-Miller, J 1989). Methicillin-resistant Staphylococcus aureus. New England Journal of Medicine, 320, 1188 1196.
11. Calfee, D. P., Durbin, L. J., Germanson, T. P., Toney, D. M., Smith, E. B. Farr, B. M. (2003). Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infection Control and Hospital Epidemiology, 24, 422 426.
12. Centers for Disease Control and Prevention 1999). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA, 282, 1123 1125.
13. Centers for Disease Control and Prevention 2001). Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison-Mississippi, 2000. MMWR Morbidity and Mortality Weekly Report, 50, 919 922.
14. Centers for Disease Control and Prevention 2003a). Methicillin-resistant staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles Country, 2000-2003. MMWR Morbidity and Mortality Weekly Report, 52, 793 795.
15. Centers for Disease Control and Prevention 2003b). Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California, and Texas, 2001-2003. MMWR Morbidity and Mortality Weekly Report, 52, 992 996.
16. Centers for Disease Control and Prevention 2003c). Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morbidity and Mortality Weekly Report, 52, 88.
17. Chambers, H. F. (2001). The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases, 7, 178 182.
18. Charlebois, E. D., Bangsberg, D. R., Moss, N. J., Moore, M. R., Moss, A. R., Chambers, H. F., et al 2002). Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clinical Infectious Diseases, 34, 425 433.
19. Cook, H. A., Furuya, E. Y., Larson, E., Vasquez, G. Lowy, F. D. (2007). Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases, 44, 410 413.
20. Creech, C. B., Kernodle, D. S., Alsentzer, A., Wilson, C. Edwards, K. M. (2005). Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatric Infectious Diseases Journal, 24, 617 621.
21. Crossley, K., Landesman, B. Zaske, D 1979). An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies. Journal of Infectious Diseases, 139, 280 287.
22. Crum-Cianfione, N 8-13-0007). Increasing rates of community-acquired MRSA infection among HIV-infected persons. Hale, A., Burgi, G., Utz, A., and Truett, H. XVI International AIDS Conference.
23. Daum, R. S., Ito, T., Hiramatsu, K., Hussain, F., Mongkolrattanothai, K., Jamklang, M., et al 2002). A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. Journal of Infectious Diseases, 186, 1344 1347.
24. Dehority, W., Wang, E., Vernon, P. S., Lee, C., Perdreau-Remington, F. Bradley, J 2006). Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. Pediatric Infectious Disease Journal, 25, 1080 1081.
25. Eady, E. A. Cove, J. H. (2003). Staphylococcal resistance revisited: Community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Current Opinion in Infectious Diseases, 16, 103 124.
26. Fleming, S. W., Brown, L. H. Tice, S. E. (2006). Community-acquired methicillin-resistant Staphylococcus aureus skin infections: Report of a local outbreak and implications for emergency department care. Journal of the American Academy of Nurse Practitioners, 18, 297 300.
27. Francis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., et al 2005). Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clinical Infectious Diseases, 40, 100 107.
28. Frazee, B. W., Salz, T. O., Lambert, L. Perdreau-Remington, F 2005). Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Annals of Emergency Medicine, 46, 401 404.
29. Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., et al 2005). Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine, 352, 1436 1444.
30. Graffunder, E. M. Venezia, R. A. (2002). Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. Journal of Antimicrobial Chemotherapy, 49, 999 1005.
31. Graham, P. L., III., Lin, S. X. Larson, E. L. (2006). A U.S. population-based survey of Staphylococcus aureus colonization. Annals of Internal Medicine, 144, 318 325.
32. Groom, A. V., Wolsey, D. H., Naimi, T. S., Smith, K., Johnson, S., Boxrud, D., et al 2001). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA, 286, 1201 1205.
33. Herold, B. C., Immergluck, L. C., Maranan, M. C., Lauderdale, D. S., Gaskin, R. E., Boyle-Vavra, S., et al 1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA, 279, 593 598.
34. Infectious Disease Society of America 2005). Diagnosis and managment of skin and soft-tissue infections. Clinical Infectious Diseases, 41, 1373 1406.
35. Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., et al 2001). Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents of Chemotherapy, 45, 1323 1336.
36. Johnston, C. P., Cooper, L., Ruby, W., Carroll, K. C., Cosgrove, S. E. Perl, T. M. (2006). Epidemiology of community-acquired methicillin-resistant Staphylococcus aureus skin infections among healthcare workers in an outpatient clinic. Infection Control and Hospital Epidemiology, 27, 1133 1136.
37. Jonas, D., Speck, M., Daschner, F. D. Grundmann, H 2002). Rapid PCR-based identification of methicillin-resistant Staphylococcus aureus from screening swabs. Journal of Clinical Microbiology, 40, 1821 1823.
38. Kaka, A. S., Rueda, A. M., Shelburne, S. A., III., Hulten, K., Hamill, R. J. Musher, D. M. (2006). Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 58, 680 683.
39. Kaplan, S. L., Hulten, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L., Versalovic, J., et al 2005). Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clinical Infectious Diseases, 40, 1785 1791.
40. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators 2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association, 298 (15 1763 1771.
41. Klevens, R. M., Morrison, M. A., Fridkin, S. K., Reingold, A., Petit, S., Gershman, K., et al 2006). Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases, 12, 1991 1993.
42. LaMar, J. E., Carr, R. B., Zinderman, C. McDonald, K 2003). Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Military Medicine, 168, 135 138.
43. Le, J. Lieberman, J. M. (2006). Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy, 26, 1758 1770.
44. Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M. O., Gauduchon, V., et al 1999). Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases, 29, 1128 1132.
45. Lowy, F. D. (1998). Staphylococcus aureus infections. New England Journal of Medicine, 339, 520 532.
46. Miller, L. G., Perdreau-Remington, F., Bayer, A. S., Diep, B., Tan, N., Bharadwa, K., et al 2007). Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: A prospective investigation. Clinical Infectious Diseases, 44, 471 482.
47. Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., et al 2005). Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. New England Journal of Medicine, 352, 1445 1453.
48. Mongkolrattanothai, K., Boyle, S., Kahana, M. D. Daum, R. S. (2003). Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clinical Infectious Diseases, 37, 1050 1058.
49. Monnet, D. L., Mackenzie, F. M., Lopez-Lozano, J. M., Beyaert, A., Camacho, M., Wilson, R., et al 2004). Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerging Infectious Diseases, 10, 1432 1441.
50. Muder, R. R., Brennen, C., Wagener, M. M., Vickers, R. M., Rihs, J. D., Hancock, G. A., et al 1991). Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Annals of Internal Medicine, 114, 107 112.
51. Munckhof, W. J., Kleinschmidt, S. L. Turnidge, J. D. (2004). Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: An in vitro study. International Journal of Antimicrobial Agents, 24, 605 608.
52. Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., et al 2001). Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clinical Infectious Diseases, 33, 990 996.
53. Obed, A., Schnitzbauer, A. A., Bein, T., Lehn, N., Linde, H. J. Schlitt, H. J. (2006). Fatal pneumonia caused by Panton-Valentine Leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver transplantation. Transplantation, 81, 121 124.
54. Pan, E. S., Diep, B. A., Carleton, H. A., Charlebois, E. D., Sensabaugh, G. F., Haller, B. L., et al 2003). Increasing prevalence of methicillin- resistant Staphylococcus aureus infection in California jails. Clinical Infectious Diseases, 37, 1384 1388.
55. Peacock, J. E., Jr., Marsik, F. J. Wenzel, R. P. (1980). Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital. Annals of Internal Medicine, 93, 526 532.
56. Prevost, G., Couppie, P., Prevost, P., Gayet, S., Petiau, P., Cribier, B., et al 1995). Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. Journal of Medical Microbiology, 42, 237 245.
57. Romano, R., Lu, D. Holtom, P 2006). Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. Journal of Athletic Training, 41, 141 145.
58. Ruhe, J. J., Monson, T., Bradsher, R. W. Menon, A 2005). Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: Case series and review of the literature. Clinical Infectious Diseases, 40, 1429 1434.
59. Saiman, L., O'Keefe, M., Graham, P. L., III., Wu, F., Said-Salim, B., Kreiswirth, B., et al 2003). Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clinical Infectious Diseases, 37, 1313 1319.
60. Salgado, C. D., Farr, B. M. Calfee, D. P. (2003). Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clinical Infectious Diseases, 36, 131 139.
61. Sanford, M. D., Widmer, A. F., Bale, M. J., Jones, R. N. Wenzel, R. P. (1994). Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases, 19, 1123 1128.
62. Saravolatz, L. D., Markowitz, N., Arking, L., Pohlod, D. Fisher, E 1982a). Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Annals of Internal Medicine, 96, 11 16.
63. Saravolatz, L. D., Pohlod, D. J. Arking, L. M. (1982b). Community-acquired methicillin-resistant Staphylococcus aureus infections: A new source for nosocomial outbreaks. Annals of Internal Medicine, 97, 325 329.
64. Scanvic, A., Denic, L., Gaillon, S., Giry, P., Andremont, A. Lucet, J. C. (2001). Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clinical Infectious Diseases, 32, 1393 1398.
65. Shopsin, B., Mathema, B., Martinez, J., Ha, E., Campo, M. L., Fierman, A., et al 2000). Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. Journal of Infectious Diseases, 182, 359 362.
66. Simor, A. E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H. R., et al 2007). Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clinical Infectious Diseases, 44, 178 185.
67. Stemper, M. E., Brady, J. M., Qutaishat, S. S., Borlaug, G., Reed, J., Reed, K. D., et al 2006). Shift in Staphylococcus aureus clone linked to an infected tattoo. Emerging Infectious Diseases, 12, 1444 1446.
68. Thompson, R. L., Cabezudo, I. Wenzel, R. P. (1982). Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine, 97, 309 317.
69. Voyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., et al 2006). Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? Journal of Infectious Diseases, 194, 1761 1770.
70. Warshawsky, B., Hussain, Z., Gregson, D. B., Alder, R., Austin, M., Bruckschwaiger, D., et al 2000). Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor. Infection Control and Hospital Epidemiology, 21, 724 727.
71. Wright, A. J. (1999). The penicillins. Mayo Clinic Proceedings, 74, 290 307.
72. Zafar, U., Johnson, L. B., Hanna, M., Riederer, K., Sharma, M., Fakih, M. G., et al 2007). Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infection Control and Hospital Epidemiology, 28 (8 966 969.